184 related articles for article (PubMed ID: 12893848)
1. Antisense oligonucleotide inhibition of Bcl-xL and Bid expression in liver regulates responses in a mouse model of Fas-induced fulminant hepatitis.
Zhang H; Taylor J; Luther D; Johnston J; Murray S; Wyatt JR; Watt AT; Koo S; York-DeFalco C; Stecker K; Dean NM
J Pharmacol Exp Ther; 2003 Oct; 307(1):24-33. PubMed ID: 12893848
[TBL] [Abstract][Full Text] [Related]
2. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis.
Zhang H; Cook J; Nickel J; Yu R; Stecker K; Myers K; Dean NM
Nat Biotechnol; 2000 Aug; 18(8):862-7. PubMed ID: 10932156
[TBL] [Abstract][Full Text] [Related]
3. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury.
Higuchi H; Miyoshi H; Bronk SF; Zhang H; Dean N; Gores GJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):866-73. PubMed ID: 11714870
[TBL] [Abstract][Full Text] [Related]
4. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
[TBL] [Abstract][Full Text] [Related]
5. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer.
Masui T; Hosotani R; Ito D; Kami K; Koizumi M; Mori T; Toyoda E; Nakajima S; Miyamoto Y; Fujimoto K; Doi R
Surgery; 2006 Aug; 140(2):149-60. PubMed ID: 16904964
[TBL] [Abstract][Full Text] [Related]
6. A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.
Zangemeister-Wittke U; Leech SH; Olie RA; Simões-Wüst AP; Gautschi O; Luedke GH; Natt F; Häner R; Martin P; Hall J; Nalin CM; Stahel RA
Clin Cancer Res; 2000 Jun; 6(6):2547-55. PubMed ID: 10873111
[TBL] [Abstract][Full Text] [Related]
7. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B virus X protein abrogates Bcl-2-mediated protection against Fas apoptosis in the liver.
Terradillos O; de La Coste A; Pollicino T; Neuveut C; Sitterlin D; Lecoeur H; Gougeon ML; Kahn A; Buendia MA
Oncogene; 2002 Jan; 21(3):377-86. PubMed ID: 11821950
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice.
Yu RZ; Zhang H; Geary RS; Graham M; Masarjian L; Lemonidis K; Crooke R; Dean NM; Levin AA
J Pharmacol Exp Ther; 2001 Feb; 296(2):388-95. PubMed ID: 11160622
[TBL] [Abstract][Full Text] [Related]
10. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes.
Woo M; Hakem A; Elia AJ; Hakem R; Duncan GS; Patterson BJ; Mak TW
J Immunol; 1999 Nov; 163(9):4909-16. PubMed ID: 10528193
[TBL] [Abstract][Full Text] [Related]
11. Fas-induced apoptosis in mouse hepatocytes is dependent on C/EBPbeta.
Mukherjee D; Kaestner KH; Kovalovich KK; Greenbaum LE
Hepatology; 2001 May; 33(5):1166-72. PubMed ID: 11343245
[TBL] [Abstract][Full Text] [Related]
12. A novel proanthocyanidin IH636 grape seed extract increases in vivo Bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver.
Ray SD; Kumar MA; Bagchi D
Arch Biochem Biophys; 1999 Sep; 369(1):42-58. PubMed ID: 10462439
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 inhibited Fas-mediated apoptosis in human hepatocellular carcinoma BEL-7404 cells.
Chang YC; Xu YH
Cell Res; 2000 Sep; 10(3):233-42. PubMed ID: 11032175
[TBL] [Abstract][Full Text] [Related]
14. NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.
Zender L; Hütker S; Mundt B; Waltemathe M; Klein C; Trautwein C; Malek NP; Manns MP; Kühnel F; Kubicka S
Hepatology; 2005 Feb; 41(2):280-8. PubMed ID: 15660391
[TBL] [Abstract][Full Text] [Related]
15. Bcl-x protects primary B cells against Fas-mediated apoptosis.
Schneider TJ; Grillot D; Foote LC; Núñez GE; Rothstein TL
J Immunol; 1997 Nov; 159(10):4834-9. PubMed ID: 9366408
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
17. Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cells.
McKenzie MD; Carrington EM; Kaufmann T; Strasser A; Huang DC; Kay TW; Allison J; Thomas HE
Diabetes; 2008 May; 57(5):1284-92. PubMed ID: 18252892
[TBL] [Abstract][Full Text] [Related]
18. Edaravone prevents Fas-induced fulminant hepatic failure in mice by regulating mitochondrial Bcl-xL and Bax.
Miyasou T; Kwon AH; Tsuji K; Qiu Z; Okumura T; Kamiyama Y
Shock; 2008 Aug; 30(2):212-6. PubMed ID: 18180697
[TBL] [Abstract][Full Text] [Related]
19. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
